companydirectorylist.com  글로벌 비즈니스 디렉토리 및 회사 디렉토리
검색 비즈니스 , 회사 , 산업 :


국가 목록
미국 회사 디렉토리
캐나다 기업 목록
호주 비즈니스 디렉토리
프랑스 회사 목록
이탈리아 회사 목록
스페인 기업 디렉토리
스위스 기업 목록
오스트리아 회사 디렉토리
벨기에 비즈니스 디렉토리
홍콩 기업 목록
중국 사업 목록
대만 기업 목록
아랍 에미레이트 회사 디렉토리


산업 카탈로그
미국 산업 디렉토리














  • Home - Precision BioSciences
    ARCUS is a novel and proprietary genome editing platform discovered and developed by scientists at Precision BioSciences ARCUS uses sequence- specific DNA-cutting enzymes, or nucleases, to insert (knock in), remove (knockout), or repair the DNA of living cells and tissues
  • Pipeline - Precision BioSciences
    Poster Preclinical safety data for PBGENE-HBV gene editing program supports advancement to clinical trials as a potentially curative treatment for chronic hepatitis B
  • News - Precision BioSciences
    DURHAM, N C -- (BUSINESS WIRE)--Aug 4, 2025-- Precision BioSciences, Inc (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo…
  • ARCUS Genome Editing - Precision BioSciences
    ARCUS is a proprietary genome editing technology discovered by scientists at Precision BioSciences ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make highly specific cuts and DNA insertions in cellular DNA
  • Who We Are - Precision BioSciences
    But rapid advances and breakthroughs mean that moving from cell culture to the clinic is now an exciting reality – and Precision has quietly built what is arguably the leading gene editing platform paving the way for the next frontier of therapeutic gene editing therapies
  • Precision BioSciences Announces Return of Programs and Conclusion of . . .
    Precision BioSciences, Inc is an advanced gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure
  • Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE . . .
    Precision BioSciences, Inc is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure
  • Our Team - Precision BioSciences
    Learn More ARCUS Genome Editing Pipeline heading Our Mission Our Team Policies Terms of Use Privacy Policy Disclaimer Cookie Policy ©2021 Precision BioSciences




비즈니스 디렉토리, 기업 디렉토리
비즈니스 디렉토리, 기업 디렉토리 copyright ©2005-2012 
disclaimer